Cirrhosis of the Liver
What liver scarring means, how it progresses, and when to start talking about a transplant.
What liver scarring means, how it progresses, and when to start talking about a transplant.
Cirrhosis is long-term scarring of the liver. When the liver is hurt again and again, by alcohol, a virus, fat buildup or an immune attack, it tries to repair itself. Each repair leaves a little scar tissue behind. Over many years, that scar tissue replaces healthy liver tissue, and the liver slowly loses its ability to do its jobs.
The U.S. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) describes cirrhosis as a condition in which the liver is scarred and permanently damaged. Researchers estimate that about 1 in 400 adults in the United States has cirrhosis, and the true number may be higher because many people do not know they have it.
Cirrhosis is not one single moment. It is a stage along a longer road. To see where it fits, read our guide to the stages of liver disease, which runs from early inflammation and fibrosis to cirrhosis and then end-stage liver disease.
Scarring also makes it harder for blood to flow through the liver. Pressure builds up in the portal vein, the large vein that carries blood from the gut to the liver. Doctors call this portal hypertension. It is behind many of the serious problems of later cirrhosis, such as fluid in the belly and swollen veins that can bleed.
Anything that injures the liver for a long time can lead to cirrhosis. According to the NIDDK, the most common causes in the United States are:
Less common causes include:
Many people have more than one cause, for example fatty liver disease plus alcohol. Knowing the cause matters, because treating it is the best way to slow the damage.
Liver doctors split cirrhosis into two main phases. The difference between them is the single most important thing to understand about your outlook.
In compensated cirrhosis, the liver is scarred but still doing enough of its work. Many people feel fine or have only mild symptoms, such as tiredness. Some people live in this phase for many years.
Cirrhosis becomes decompensated when the liver can no longer keep up and a major complication appears. International experts (the Baveno VII consensus) define decompensation by events such as ascites (fluid in the belly), bleeding from swollen veins (varices) and hepatic encephalopathy (confusion caused by toxins the liver can't clear). Jaundice, yellow skin or eyes, is also a warning sign of a failing liver. Our page on decompensated cirrhosis walks through each one.
A large review of 118 studies by D'Amico and colleagues described four clinical stages. The table shows the share of people who died within one year at each stage in the original research cohort.
| Stage | Phase | What it means | Deaths within 1 year (original cohort) |
|---|---|---|---|
| 1 | Compensated | No varices, no ascites | About 1% |
| 2 | Compensated | Varices present, but no bleeding and no ascites | About 3% |
| 3 | Decompensated | Ascites, with or without varices, no bleeding | About 20% |
| 4 | Decompensated | Variceal bleeding, with or without ascites | About 57% |
These figures come from patients followed decades ago, before many of today's treatments. Later studies have found different numbers, so treat the table as a picture of how risk rises from stage to stage, not as a prediction for any one person.
Early cirrhosis often causes no symptoms at all. Many people find out from a routine blood test, a scan done for another reason, or only after a complication. When early symptoms do appear, the NIDDK lists:
As the liver gets worse, later symptoms can include:
The later symptoms are signs that cirrhosis may be turning decompensated. Some, like vomiting blood or sudden confusion, are medical emergencies.
Doctors usually combine several kinds of tests:
Once cirrhosis is found, your team will also use blood tests to track how sick the liver is over time. One of these measures is the MELD score, which matters a great deal later if a transplant is needed.
There is no medicine that cures cirrhosis or erases scarring. But treating the cause can slow or stop further damage, and that can make a real difference. The NIDDK lists these steps:
Your team will also treat or prevent complications. For example, medicines can lower the pressure in swollen veins to cut the risk of bleeding. Treating complications early may keep them from getting worse.
Cirrhosis raises the risk of the most common type of liver cancer, hepatocellular carcinoma (HCC). Most people who develop this cancer already have cirrhosis. Cancer found early is much easier to treat, and in some cases a liver transplant is part of that treatment.
The American Association for the Study of Liver Diseases (AASLD) recommends surveillance for most people with cirrhosis using a liver ultrasound plus an AFP blood test about every 6 months. Ask your doctor whether you are on this schedule, and put the dates on your calendar.
This is often the first question people ask, and there is no single answer. Outlook depends most on whether cirrhosis is compensated or decompensated, on the cause and whether it can be treated, and on overall health.
What large studies have found:
These numbers describe large groups, not you. They also come from older research, before today's hepatitis C cures and other advances. Some people live many years with compensated cirrhosis, and a liver transplant can greatly improve the outlook for people whose disease progresses. Your hepatologist can tell you what your own test results suggest.
A liver transplant replaces the scarred liver with a healthy one from a donor. Doctors consider it when cirrhosis leads to liver failure and other treatments are no longer enough.
Timing matters. The AASLD and the American Society of Transplantation advise that evaluation for a transplant should be considered once a person with cirrhosis has had a first major complication (ascites, hepatic encephalopathy or variceal bleeding) or once the MELD score reaches 15 or higher. You can estimate your number with our MELD calculator, then bring it to your next appointment.
Referral is not the same as being listed. A transplant center will run its own evaluation of your liver, heart, kidneys, support system and more. Learn more about who qualifies for a liver transplant and how the liver transplant waiting list works.
Centers differ in how many transplants they do and how long people wait. It is worth comparing liver transplant centers early. Some patients also register at more than one center; our dual-listing guide explains how that works.
You do not have to wait for your doctor to bring it up. It is reasonable to ask, "Should I be referred to a transplant center?" at any visit after a cirrhosis diagnosis.
Doctors divide cirrhosis into two main phases. In compensated cirrhosis the liver is scarred but still working, and many people have few symptoms. In decompensated cirrhosis a major complication has appeared, such as fluid in the belly (ascites), bleeding varices or confusion (hepatic encephalopathy). A widely used system splits these into four clinical stages, with risk rising at each one.
It depends mostly on the stage. In large studies, people with compensated cirrhosis had a median survival of more than 12 years, and people with decompensated cirrhosis had a median survival of about 2 years without a transplant. These are group averages from older research, not predictions for one person. Your hepatologist can explain what your own results suggest.
There is no medicine that cures cirrhosis or erases the scarring. But treating the cause, such as stopping alcohol, curing hepatitis C or controlling hepatitis B, can slow or stop further damage. Some people with decompensated cirrhosis even improve enough to be called recompensated. See our page on decompensated cirrhosis.
Early cirrhosis often has no symptoms. When symptoms appear, they can include tiredness, weakness, poor appetite, weight loss without trying, nausea and itchy skin. Later signs include easy bruising, swelling of the legs or belly, yellow skin or eyes, and confusion.
The most common causes in the United States are alcohol-associated liver disease, fatty liver disease (now called MASLD and MASH, formerly NAFLD and NASH), and chronic hepatitis C and hepatitis B. Less common causes include autoimmune hepatitis, bile duct diseases such as PBC and PSC, and inherited diseases such as hemochromatosis and Wilson disease.
The AASLD recommends liver cancer surveillance for most people with cirrhosis using a liver ultrasound plus an AFP blood test about every 6 months. Ask your doctor whether you are on this schedule.
AASLD and American Society of Transplantation guidance says transplant evaluation should be considered after a first major complication (ascites, hepatic encephalopathy or variceal bleeding) or once the MELD score reaches 15 or higher. Learn more about who qualifies for a liver transplant.
Medically reviewed by James F. Trotter, MD and Joseph S. Redman, MD, PhD of the National Friends Medical Advisory Board on . Reviewers check clinical statements against the cited sources; data tables come from the public SRTR program-specific reports and OPTN policy.
Published by Friends of the National Liver Waiting List, a 501(c)(3) patient advocacy charity. Updated . Not medical advice: talk with your hepatologist or transplant team about your own care.